Insulin Analog [EPC]

185660 reported adverse events

Drugs of this class: INSULIN LISPRO INSULIN GLARGINE INSULIN DETEMIR INSULIN GLARGINE AND LIXISENATIDE INSULIN GLULISINE INSULIN LISPRO-AABC

These side effects are most commonly reported by patients taking drugs of the Insulin Analog [EPC] class:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 40788
1 BLOOD GLUCOSE DECREASED 10425
2 DRUG INEFFECTIVE 9763
3 NAUSEA 8405
4 INCORRECT DOSE ADMINISTERED 6865
5 HYPOGLYCAEMIA 6581
6 MALAISE 6079
7 FATIGUE 5724
8 DIARRHOEA 5637
9 DYSPNOEA 5584
See all common reactions for Insulin Analog [EPC]

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INTERCEPTED PRODUCT SELECTION ERROR 253 0.5406
1 HYPOGLYCAEMIA UNAWARENESS 168 0.5385
2 ANTI-INSULIN ANTIBODY POSITIVE 96 0.4706
3 HYPOGLYCAEMIC UNCONSCIOUSNESS 763 0.4563
4 DEVICE OPERATIONAL ISSUE 664 0.3724
5 HYPOGLYCAEMIC SEIZURE 273 0.3664
6 BLOOD KETONE BODY 96 0.3664
7 DIABETIC RETINOPATHY 785 0.3504
8 INSULIN RESISTANCE 394 0.3325
9 SHOCK HYPOGLYCAEMIC 119 0.3132
See all enriched reactions for Insulin Analog [EPC]